{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:49:47Z","timestamp":1791528587683,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejmech.2022.114115","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T11:37:34Z","timestamp":1641901054000},"page":"114115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Novel PHD2\/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-3227","authenticated-orcid":false,"given":"Huiqiang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3194-9334","authenticated-orcid":false,"given":"Deguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-938X","authenticated-orcid":false,"given":"Yong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmech.2022.114115_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: a multinational, multicenter study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2022.114115_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.2040-4603.2012.tb00431.x","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ejmech.2022.114115_bib3","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114115_bib4","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","article-title":"Acute kidney injury in critically ill patients with COVID-19","volume":"46","author":"Gabarre","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejmech.2022.114115_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1021\/mp400720w","article-title":"Drug-induced nephrotoxicity: clinical impact and preclinical in\u00a0vitro models","volume":"11","author":"Tiong","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2022.114115_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/07853890.2018.1489142","article-title":"Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury","volume":"50","author":"Yan","year":"2018","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejmech.2022.114115_bib7","doi-asserted-by":"crossref","first-page":"k4891","DOI":"10.1136\/bmj.k4891","article-title":"Sepsis associated acute kidney injury","volume":"364","author":"Poston","year":"2019","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2022.114115_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar1","year":"2018","journal-title":"J.\u00a0Nephrol."},{"key":"10.1016\/j.ejmech.2022.114115_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000078452","article-title":"Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephro-toxicity","volume":"24","author":"Mishra","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114115_bib10","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/ijms20123011","article-title":"Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury","volume":"20","author":"Holditch","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114115_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2019.04.001","article-title":"Acute kidney injury overview: from basic findings to new prevention and therapy strategies","volume":"200","author":"Gonsalez","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.ejmech.2022.114115_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nep.13466","article-title":"Epigenetic targeting for acute kidney injury","volume":"23","author":"Zhuang","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.ejmech.2022.114115_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41419-018-0374-7","article-title":"Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2022.114115_bib14","doi-asserted-by":"crossref","first-page":"e3139","DOI":"10.1038\/cddis.2017.552","article-title":"Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury","volume":"8","author":"Ma","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2022.114115_bib15","first-page":"2620","article-title":"The nephroprotective effect of MS-275 on lipopolysaccharide (LPS)-induced acute kidney injury by inhibiting reactive oxygen species (ROS)-oxidative stress and endoplasmic reticulum stress","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejmech.2022.114115_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2012111055","article-title":"Histone deacetylase inhibitor enhances recovery after AKI","volume":"24","author":"Cosentino","year":"2013","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114115_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/CS20171417","article-title":"Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury","volume":"132","author":"Tang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejmech.2022.114115_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla: its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114115_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/1440-1681.12005","article-title":"Regulation of hypoxia-inducible factor in kidney disease","volume":"40","author":"Nangaku","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejmech.2022.114115_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40620-016-0359-5","article-title":"Linking acute kidney injury to chronic kidney disease: the missing links","volume":"30","author":"Kaballo","year":"2017","journal-title":"J.\u00a0Nephrol."},{"key":"10.1016\/j.ejmech.2022.114115_bib21","doi-asserted-by":"crossref","first-page":"172711","DOI":"10.1016\/j.ejphar.2019.172711","article-title":"Factors affecting the transition of acute kidney injury to chronic kidney disease: potential mechanisms and future perspectives","volume":"865","author":"Ogbadu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114115_bib22","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/ijms20194941","article-title":"Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: an updated view","volume":"20","author":"Guzzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114115_bib23","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2005121302","article-title":"Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure","volume":"17","author":"Bernhardt","year":"2006","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114115_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/CS20171625","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejmech.2022.114115_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13543784.2018.1417386","article-title":"Roxadustat in the treatment of anemia in chronic kidney disease","volume":"27","author":"Del Vecchio","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2022.114115_bib26","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1021\/acs.jmedchem.6b01242","article-title":"Discovery of N-[bis(4-methoxyphenyl)methyl]- 4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1\u22123 (HIF PHD1\u22123) for the treatment of anemia","volume":"59","author":"Debenham","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114115_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2017-0301","article-title":"The european medicines agency review of panobinostat (Farydak) for the treatment of adult patients with relapsed and\/or refractory multiple myeloma","volume":"23","author":"Tzogani","year":"2018","journal-title":"Oncol."},{"key":"10.1016\/j.ejmech.2022.114115_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2018.10.012","article-title":"Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma","volume":"442","author":"Choi","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2022.114115_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","article-title":"Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology","volume":"7","author":"Semenza","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2022.114115_bib30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI31750","article-title":"HIF-1 and HIF-2: working alone or together in hypoxia?","volume":"117","author":"Ratcliffe","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.114115_bib31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel\u2212Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114115_bib32","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1021\/jm400386j","article-title":"Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses","volume":"56","author":"Rabinowitz","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib33","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib34","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1021\/acs.jmedchem.8b00549","article-title":"Click chemistry-based discovery of [3-hydroxy-5-(1H-1,2,3-triazol-4-yl)picolinoyl]glycines as orally active hypoxia-inducing factor prolyl hydroxylase inhibitors with favorable safety profiles for the treatment of anemia","volume":"61","author":"Wu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"De Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2022.114115_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2017.04.013","article-title":"Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors","volume":"135","author":"De Vreese","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib38","doi-asserted-by":"crossref","first-page":"112887","DOI":"10.1016\/j.ejmech.2020.112887","article-title":"Mercaptoacetamide: a promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors","volume":"209","author":"Tavares","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib39","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejmech.2018.08.073","article-title":"HDAC as onco target: reviewing the synthetic approaches with SAR study of their inhibitors","volume":"158","author":"Sangwan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib40","doi-asserted-by":"crossref","first-page":"112648","DOI":"10.1016\/j.ejmech.2020.112648","article-title":"Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic pro\ufb01le in breast cancer","volume":"205","author":"Yao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5582\/bst.2019.01055","article-title":"Design, synthesis and biological evaluation of 4-piperidin-4-yl-triazole derivatives as novel histone deacetylase inhibitors","volume":"13","author":"Miao","year":"2019","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.ejmech.2022.114115_bib42","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1021\/acs.jmedchem.8b00189","article-title":"Kinase and histone deacetylase hybrid inhibitors for cancer therapy","volume":"62","author":"Luan","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2110-5820-1-3","article-title":"Erythropoietin (EPO) in acute kidney injury","volume":"1","author":"Moore","year":"2011","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.ejmech.2022.114115_bib44","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/CCM.0000000000004853","article-title":"A\u00a0post hoc analysis of osmotherapy use in the erythropoietin in traumatic brain injury study-associations with acute kidney injury and mortality","volume":"49","author":"Skrifvars","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejmech.2022.114115_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ndt\/gfq601","article-title":"Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model","volume":"26","author":"Ishii","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2022.114115_bib46","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114115_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/acsmedchemlett.5b00394","article-title":"Affinity-based fluorescence polarization assay for high-throughput screening of prolyl hydroxylase 2 inhibitors","volume":"6","author":"Lei","year":"2015","journal-title":"ACS Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:35:24Z","timestamp":1759329324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":47,"alternative-id":["S0223523422000174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114115","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel PHD2\/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114115"}}